8-K: Ensign Group Reports Strong Q3 2026, Raises Earnings Guidance

The Ensign Group announced robust third quarter 2026 financial results, exceeding prior year performance and leading to an upward revision of its full-year earnings outlook.

Summary

• The Ensign Group reported strong third quarter 2026 results, with GAAP diluted EPS of $1.76 and adjusted diluted EPS of $2.03, representing significant year-over-year increases.
• GAAP net income rose 24.4% to $104.3 million, and adjusted net income increased by 24.9% to $120.5 million.
• Consolidated revenue grew 14.5% to $1.48 billion.
• Occupancy rates improved across Same Facilities (84.1%) and Transitioning Facilities (86.1%).
• Skilled mix revenue and Medicare revenue saw substantial increases.
• The company raised its 2026 annual earnings guidance to $7.94 $8.02 per diluted share.
• Acquisition activity accelerated, with 22 new operations added during the quarter and since.
• Liquidity remains strong with $337.6 million in cash and $731.6 million in available credit capacity.

Sentiment

Score: 9

Explanation: StockSavvy.ai views this as a strongly positive report, with significant year-over-year growth in key financial and operational metrics, alongside an increase in annual earnings guidance.

Positives

• GAAP diluted EPS increased by 23.9% to $1.76 compared to the prior year quarter.
• Adjusted diluted EPS increased by 23.8% to $2.03 compared to the prior year quarter.
• GAAP net income increased by 24.4% to $104.3 million.
• Adjusted net income increased by 24.9% to $120.5 million.
• Consolidated revenue increased by 14.5% to $1.48 billion.
• Same Facilities occupancy increased by 1.6% to 84.1%.
• Transitioning Facilities occupancy increased by 3.9% to 86.1%.
• Same Facilities skilled mix revenue increased by 10.7%.
• Medicare revenue for Same Facilities increased by 11.1%.
• 22 new operations were added during the quarter and since, accelerating acquisition growth.
• Strong liquidity with $337.6 million in cash and $731.6 million in available credit capacity.
• 2026 annual earnings guidance was raised to $7.94 $8.02 per diluted share.

Negatives

• The company's cash and cash equivalents decreased from $503.9 million at the end of the previous year to $337.6 million at the end of the quarter, a decrease of $166.3 million for the nine-month period, primarily due to investing activities.
• While overall revenue increased, the 'Recently Acquired Facility Results' showed a decrease in skilled mix by nursing days and revenue compared to the prior year, though this is expected given the nature of acquisitions.

Risks

• Reduced prices and reimbursement rates for services.
• Ability to acquire, develop, manage, or improve operations.
• Increasing borrowing costs due to additional indebtedness.
• Ability to access capital on a cost-effective basis.
• Operating margins and profitability could suffer if unable to grow and manage operations effectively.
• Competition from other companies in the industry.
• Ability to defend claims and lawsuits, including professional liability and regulatory claims.
• Impact of existing or proposed government regulations, or adoption of new laws and regulations.

Future Outlook

The company raised its 2026 annual earnings guidance to $7.94 to $8.02 per diluted share, up from $7.75 to $7.85. Annual revenue guidance was raised to $5.89 billion to $5.92 billion. Management expects to maintain a healthy pace of acquisitions.

Management Comments

• "We are thrilled to report another outstanding quarter. Our teams continue to demonstrate their unwavering commitment to dignifying post-acute care through moments of truth."
• "We believe culture is not separate from performance, it is the foundation that makes sustainable clinical, operational and financial performance possible."
• "Our clinical leaders also continue to drive outstanding outcomes, which is particularly impressive given our growth over the past several years."
• "These results reinforce our position as the provider of choice in our markets and demonstrate our ability to create long-term value through sustained clinical excellence."
• "These improvements in occupancy and skilled mix clearly demonstrate that patients, families, hospital systems, physicians, and managed care organizations continue to choose Ensign affiliated operations because of the outcomes our teams achieve and the distinctive culture and experience our local teams create every day."
• "Due to the strength of the third quarter and our confidence in the fourth quarter, we are increasing our annual 2026 earnings guidance..."
• "We continue to acquire new operations with significant long-term upside and expect to maintain a healthy pace of growth as we expand our mission driven approach to transform and dignify post-acute care."
• "Managements annual guidance is based on diluted weighted average common shares outstanding of approximately 59.5 million and a 25.0% tax rate."

Industry Context

StockSavvy.ai notes that Ensign Group's strong performance, particularly in occupancy and skilled mix, reflects a continued demand for post-acute healthcare services. The company's ability to integrate acquisitions and maintain clinical excellence appears to be a key differentiator in a competitive landscape.

Comparison to Industry Standards

• Same Facilities achieved CMS Quality Measure ratings that were 21% better than industry peers in operating states.
• Same Facilities achieved CMS Cycle 1 survey inspection results that were 15% better than industry peers in operating states.
• Over 80% of skilled nursing operations earned a CMS Quality Measure rating of 4 or 5 stars, indicating performance above many industry benchmarks.
• Short-stay residents achieved functional improvement rates 30% better than industry peers in operating states.
• Long-stay residents had antipsychotic medication rates 28% better than industry peers in operating states.
• Administrator turnover for Same Facilities was 45% lower than industry peers in operating states, suggesting greater operational stability compared to competitors.

Legal Proceedings

• Litigation arising outside of the ordinary course of business is noted as an adjustment in non-GAAP financial measures.

Related Party Transactions

• Management fees and interest from intercompany agreements between Standard Bearer and the Company and its independent subsidiaries are noted.

Stakeholder Impact

• Shareholders: Positive impact due to increased earnings guidance and strong financial performance, with continued dividend payments.
• Employees: Culture of compassion, accountability, and ownership is highlighted as a foundation for performance, suggesting a positive internal environment.
• Patients/Families: Improved clinical outcomes and resident-centered care are emphasized, indicating a positive impact on care recipients.
• Hospital Systems/Managed Care Organizations: Continued choice of Ensign-affiliated operations due to achieved outcomes and distinctive culture, suggesting strong partnerships.
• Suppliers/Creditors: Strong liquidity and available credit capacity suggest financial stability, which is generally positive for suppliers and creditors.

Next Steps

• Continue to acquire new operations and expand the company's mission-driven approach.
• Continue to develop strong local leadership and clusters in new markets.
• Build the necessary infrastructure to support disciplined growth.
• Continue to source, underwrite, and carefully select acquisition opportunities.
• Plan for new additions in the upcoming year.
• Continue to pay quarterly cash dividends.

Key Dates

Recommendation

The company delivered exceptionally strong Q3 results with significant year-over-year growth in key metrics, exceeding expectations. The upward revision of 2026 earnings guidance, coupled with aggressive and successful acquisition growth, robust clinical performance, and strong liquidity, indicates a positive trajectory. The consistent focus on culture and clinical excellence, which translates into operational and financial success, positions Ensign Group favorably for continued outperformance.

Keywords

post-acute healthcare, skilled nursing, senior living, healthcare operations, healthcare real estate, acquisitions, occupancy rates, Medicare revenue